5 Key Takeaways
-
1
In a retrospective cohort study using TriNetX records, statin use was associated with a 15% lower 5-year risk of developing open-angle glaucoma.
-
2
The association with lower glaucoma incidence persisted at 10 years, with a hazard ratio of 0.90.
-
3
Among patients with established glaucoma, statin use was associated with lower 5-year rates of incisional surgery, minimally invasive surgery, laser treatment, and ocular hypotensive prescriptions.
-
4
The observational study lacked detailed intraocular pressure, visual field, and optic nerve measurements and could not establish causality.
-
5
The researchers said prospective randomized trials are needed to determine whether statins reduce glaucoma onset or progression.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
